Pinto ME, Manrique HA. Withdrawal of sibutramine for cardiovascular disease risk. Rev Peru Med Exp Salud Publica [Internet]. 2010 Sep. 28 [cited 2024 Nov. 21];27(3). Available from: https://rpmesp.ins.gob.pe/index.php/rpmesp/article/view/1517